10 juli 2011: ik ben kanker-actueel aan het herzien en kwak onderstaande studie tegen en laat deze staan omdat deze m.i. nog steeds relevante informatie geeft.

Een persoonlijke opmerking hierbij: zouden al die mensen die geld geven aan het KWF zich wel realiseren dat het overgrote deel van hun geld zelden of nooit naar dit soort onderzoek gaat. Zelden of nooit wordt onderzoek gedaan met KWF geld naar effecten van goede niet toxische zorg en middelen. Iets wellicht om over na te denken.

Chest. 2005 Aug;128(2):684-9.

Zilvernitraat is ter behandeling van pleurale effusie - borstvlies- of longproblemen (ontstekingen - vocht) - zeker zo effectief als talk (zie no. 973 in literatuurlijst: talk is voor dit doel superieur aan doxorubicine!!). Dit blijkt uit een gerandomiseerde dubbelblinde studie bij 60 deelnemende patiënten. Echter omdat de deelnemende patiënten in een laatste stadium van hun ziekte verkeerden zijn veel patiënten (20%) niet meer op komen dagen voor de controles en kan deze studie niet bewijzen dat het verschil ook statistisch significant is. Toch lijkt zilvernitraat een goed en veilig middel tegen borstvlies- en longproblemen als ontstekingen en vochtophoping. Hier het uitgebreide abstract van deze studie.

Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions.

Paschoalini Mda S, Vargas FS, Marchi E, Pereira JR, Jatene FB, Antonangelo L, Light RW.
Perola Byington Hospital, Sao Paulo, Brazil.

STUDY OBJECTIVES: To compare the efficacy and the safety of talc slurry and silver nitrate (SN) in the treatment of symptomatic malignant pleural effusions.

PATIENTS AND METHODS: Sixty patients were enrolled into the study, and all received a chest tube (26F or 28F) that was placed using local anesthesia. The patients were randomized to receive either 5 g talc diluted to a total volume of 50 mL with saline solution or 20 mL 0.5% SN through the chest tube. Patients were clinically evaluated before and after treatment regarding pain, and were evaluated at monthly intervals with respect to the effectiveness of pleurodesis. Eleven patients did not return for their 30-day follow-up visit and were excluded from further analysis. Pleurodesis therapy was considered to be successful if there was no recurrence of the effusion. The patients who did not have a pleurodesis at one visit were excluded from subsequent visits.

RESULTS: Forty-nine patients returned at 30 days for follow-up, including 24 patients who received SN and 25 who received talc. The groups were similar in age (p = 0.23), sex (p = 0.70), Karnofsky index (p = 0.94), and pathology (p = 0.68). After the induction of pleurodesis, neither the total mean (+/- SE) fluid drainage (SN, 901 +/- 125 mL; talc, 766 +/- 74 mL; p = 0.36) nor the level of pain (SN, 2.58 +/- 0.26; talc, 2.62 +/- 0.30; p = 0.91) differed significantly between the groups, and no patient in either group developed ARDS. The mean number of days spent in the hospital was nearly identical (SN group, 3.7 +/- 0.15 days; talc group, 3.6 +/- 0.13 days; p = 0.47). Both SN and talc were effective agents. Thirty days after the procedure, 23 of 24 patients (96%) who had received SN and 21 of 25 patients (84%) who had received talc showed an effective pleurodesis (p = 0.35). Similar results were observed after 60 days (SN group, 18 of 18 patients [100%]; talc group, 13 of 13 patients [100%]; p = > 0.99), 90 days (SN group, 16 of 16 patients [100%]; talc, 8 of 9 patients [89%]; p = 0.36), and 120 days (SN group, 4 of 4 patients [100%]; talc group, 4 of 4 patients [100%]; p > 0.99).

CONCLUSIONS: The present study suggests that SN is an effective agent for producing a pleurodesis. In the present study, SN showed a tendency to be more effective than talc, but the power of the test to detect a significance difference was low in this small group of patients. The side effects of 0.5% SN appear to be minimal, but since only a small number of patients received SN and nearly 20% of the patients were lost to follow-up, significant long-term side effects cannot be excluded. Since SN appears to be as effective as talc, and since there is no evidence that it induces ARDS as has been reported with talc, it should be considered as an alternative to talc for the production of a pleurodesis.

Publication Types:
Clinical Trial
Randomized Controlled Trial

PMID: 16100154 [PubMed - indexed for MEDLINE]


Plaats een reactie ...

Reageer op "Zilvernitraat gaat minstens net zo goed als talk long- en borstvliesproblemen ( ontstekingen/vocht) tegen. Talk is al superieur aan de chemo doxorubicine en nu lijkt zilvernitraat nog effectiever dan talk."


Gerelateerde artikelen
 

Gerelateerde artikelen

All-Trans-Retinoic Acid - >> Antioxidanten - vitamines >> Acetylcysteine (Glutathion) >> Astragalus polysaccharide >> Bexarotene - een bewerkte >> Broccoli voorkomt longkanker >> Chinese kruiden mix - injecties >> Hydrazine sulfaat vermindert >> Melatonine naast chemo geeft >> OK-432 zorgt in vergelijking >>